Insulet | PODD - Pre Tax Profit



Insulet reported $28.4M in Pre-Tax Profit for its fiscal quarter ending in June of 2025.


Pre Tax Profit Change Date
Abbott USD 2.15B 372M Jun/2025
Align Technology USD 173.52M 33.07M Jun/2025
AtriCure USD -5929000 579K Jun/2025
Avanos Medical USD -75900000 85.6M Jun/2025
Baxter International USD -3000000 286M Mar/2025
Becton, Dickinson and Co. USD 703M 340M Jun/2025
Boston Scientific USD 941M 302M Jun/2025
Cardinal Health USD 384M 281M Jun/2025
Cooper Companies USD 151.9M 7.4M Jul/2025
Dexcom USD 241.1M 86.8M Jun/2025
Edwards Lifesciences USD 400.2M 33.7M Jun/2025
Eli Lilly USD 6.78B 3.32B Jun/2025
Globus Medical USD 188.17M 84.5M Jun/2025
ICU Medical USD 33.68M 44.58M Jun/2025
Insulet USD 28.4M 19.7M Jun/2025
Integra LifeSciences USD -530952000 500.92M Jun/2025
J&J USD 13.63B 8.21B Mar/2025
Masimo USD 55.4M 13M Jun/2025
Medtronic USD 1.87B 612M Jul/2025
Merit Medical Systems USD 43.38M 5.42M Jun/2025
Roche Holding CHF 1.78B 2.33B Dec/2024
Solventum Corp 293M 74M Mar/2025
Stryker USD 1.02B 252M Jun/2025
Tandem Diabetes Care USD -57722000 64.37M Jun/2025
Teleflex USD 135.25M 26.3M Jun/2025
West Pharmaceutical Services USD 162M 51.5M Jun/2025
Zimmer Biomet Holdings USD 224.6M 4.4M Jun/2025